Forian

Forian AAQS

Delisted

The The AAQS of Forian (FORA) as of Nov 12, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Forian has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Forian in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Forian AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2017
4.00 USD
Jan 1, 2018
4.00 USD
Jan 1, 2019
4.00 USD
Jan 1, 2020
4.00 USD
Jan 1, 2021
4.00 USD
Jan 1, 2022
4.00 USD
Jan 1, 2023
4.00 USD
Jan 1, 2024
4.00 USD
The Forian AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forian Stock analysis

What does Forian do? Forian, Inc. generates revenue through its Information and Software segment, which licenses data management and analytics products to healthcare life sciences, payer, and provider customers. The Services segment offers implementation, support, and training services on a contractual basis to these same segments. The Other segment provides security and marketing services, primarily through its security and marketing operations. The company's data management solution organizes, normalizes, standardizes, integrates, enhances, and publishes transactional information for customers across traditional and emerging healthcare sectors. Patient registries solutions help clients understand disease progression, treatment protocols, and therapeutic effectiveness through data-driven insights. Forian's customers within the healthcare payer and provider segments purchase its data management capabilities and analytics tools to optimize operational, clinical, and financial performance. The life sciences segment uses its information and software products for research and development purposes. The company's services include implementation, support, and training, which are contracted by customers seeking to integrate Forian's solutions into their workflows. Security and marketing services in the Other segment are provided to support broader business operations. The Information and Software segment licenses products that include data management and analytics solutions tailored for healthcare organizations. Services segment contracts focus on implementation, support, and training for customers using these solutions. The Other segment's security and marketing services are secondary operations that complement the primary business model. Forian's offerings enable healthcare organizations to measure performance across clinical, operational, and financial dimensions through standardized data processes. Forian is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Forian stock

The AAQS of Forian is 4 in 2024.

On Eulerpool you can find the complete historical development of The AAQS Forian since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Forian

All Key Metrics — Forian